|
References: K
- Kafantaris, V. 1995. Treatment of bipolar disorder in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 34:732-748.
- Kapur, S., and G. Remington. 1996. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 153:466-476.
- Karjoo, M., and R. Kane. 1995. Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. Arch. Pediatr. Adolesc. Med. 149:267-271.
- Karrer, R., M. Nelson, and G. C. Galbraith. 1979. Psychophysiological research with the mentally retarded. In N. R. Ellis (ed.), Handbook of mental deficiency, psychological theory, and research, 2d
ed. Hillsdale, N.J.: L. Erlbaum Associates, pp. 231-288.
- Kastner, R., R. Finesmith, and K. Walsh. 1993. Long-term adminstration of valproic acid in the treatment of affective symptoms in people with mental retardation. J. Clin. Psychopharmacol. 13:448-451.
- Keck, P. E., S. L. McElroy, and S. M. Strakowski. 1998. Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J. Clin. Psychiatry 59:74-81.
- Keller, M. B., J. P. McCullough, D. N. Klein, B. Arnow, D. L. Dunner, A. J. Gelenberg, J. C. Markowitz, C. B. Nemeroff, J. M. Russell, M. E. Thase, M. H. Trivedi, and J. Zajecka. 2000. A comparison of
nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression [see comments]. N. Engl. J. Med. 342:1462-1470.
- Keogh, M. J. 1992. Intervention to enhance attention skills in children with attention deficit hyperactivity disorder. In R. J. Hagerman and P. McKenzie (eds.), 1992 International Fragile X Conference
proceedings. Dillon, Colo.: National Fragile X Foundation and Spectra Publishing, pp. 251-259.
- Klein, D. F. 1964. Delineation of two drug responsive anxiety syndromes. Psychopharmacology (Berl.) 5:397-408.
- Kofoed, L., G. Tadepalli, J. R. Oesterheld, S. Awadallah, and R. Shapiro. 1999. Case series: Clonidine has no systematic effects on PR or QTc intervals in children. J. Am. Acad. Child Adolesc.
Psychiatry 38:1193-1196.
- Kowatch, R. A., T. Suppes, T. J. Carmody, J. P. Bucci, J. H. Hume, M. Kromelis, G. J. Emslie, W. A. Weinberg, and A. J. Rush. 2000. Effect size of lithium, divalproex sodium, and carbamazepine in
children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 39:713-720.
- Kramer, P. D. 1993. Listening to Prozac. New York: Viking/Penguin.
- Kumra, S., D. Herion, L. K. Jacobsen, C. Briguglia, and D. Grothe. 1997. Case study: Risperidone-induced hepatotoxicity in pediatric patients [see comments]. J. Am. Acad. Child Adolesc. Psychiatry
36:701-705.
|
This article is not intended to give medical advice for individual cases. Any change in medical treatment
should be done in consultation with appropriate medical personnel. This article is written for medical professionals. Some of the terms will be unfamiliar to those who are not trained in medical fields.
*This article is from the chapter on treatment in the 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research edited
by Randi Jenssen Hagerman, M.D. and Paul Hagerman, M.D., Ph.D., to be published May 2002. It is included with permission from The Johns Hopkins University Press. References to other chapters refer to chapters in
the book which are not included as part of this website.
The complete 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research can be ordered from the National Fragile X Foundation by calling
1-800-688-8765 or from The Johns Hopkins University Press at 1-800-537-5487.
|
|
Medical Follow-up Pharmacotherapy Future Prospects
Outline Medications Medical Conditions
References: A, B, C, D, EF, G, H, IJ, K, L, M, NOP, QR, S, T, UVWXYZ
|
|
